The exclusion of patients with confirmed monogenic immunodeficiencies may reduce the generalizability of the findings to all CVID patients, especially considering some monogenic mutations could be linked to higher susceptibility to neoplasia, such as in the NFK-B signaling pathway implicated in many hallmarks for carcinogenesis (31). This evidence concerns the gene NFKB1 and immune system disorder.